26 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19347877 | DEVICES FOR CELL LYSIS AND METHODS OF USE THEREOF | BEISNER, WILLIAM H | 1799 | Non-Final OA | Oct 02, 2025 |
| 19013836 | METHODS FOR DETECTING AAV | XU, XIAOYUN | 1797 | Final Rejection | Jan 08, 2025 |
| 18644528 | HUMANIZED ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF | MIDDLETON, DANAYA L | 1674 | Non-Final OA | Apr 24, 2024 |
| 18628338 | FLUID GUIDE SYSTEM USABLE FOR DRUG HANDLING, E.G. FOR RECONSTITUTION, CORRESPONDING MEDICAL DEVICE, METHOD AND COMPUTER RELATED ITEMS | SMALE, AVERY E | 3783 | Final Rejection | Apr 05, 2024 |
| 18545029 | DRUG FORMULATIONS OF (R)-1-(1-ACRYLOYLPIPERIDIN-3-YL)-4-AMINO-3-(4-PHENOXYPHENYL)-1H-IMIDAZO[4,5-C]PYRIDIN-2(3H)-ONE | JACKSON, SHAWQUIA | 1626 | Non-Final OA | Dec 19, 2023 |
| 18470507 | METHODS FOR QUANTIFYING DRUG CONCENTRATION IN A PRODRUG COMPOSITION | ADAMS, MICHELLE | 1797 | Non-Final OA | Sep 20, 2023 |
| 18236462 | METHODS FOR TREATING RECEPTOR-INTERACTING PROTEIN KINASE 1-MEDIATED DISEASES | HAVLIN, ROBERT H | 1626 | Non-Final OA | Aug 22, 2023 |
| 18317772 | METHODS OF TREATING METACHROMATIC LEUKODYSTROPHY | SHIBUYA, MARK LANCE | 1631 | Non-Final OA | May 15, 2023 |
| 18141128 | INDUCTION OF IMMUNE TOLERANCE BY USING METHOTREXATE | LEE, CHIHYI NMN | 1628 | Non-Final OA | Apr 28, 2023 |
| 18304519 | Compositions and Methods for Treating Spinal Muscular Atrophy | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Apr 21, 2023 |
| 18299640 | USE OF AN IRAK4 MODULATOR FOR GENE THERAPY | KOSAR, ANDREW D | 1625 | Non-Final OA | Apr 12, 2023 |
| 18025853 | COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Mar 10, 2023 |
| 18007433 | METHODS FOR REDUCING GLYCOSPHINGOLIPID CONCENTRATION IN BRAIN TISSUE AND METHODS OF TREATMENT OF NEURODEGENERATIVE DISEASES INVOLVING THE SAME | SZNAIDMAN, MARCOS L | 1628 | Non-Final OA | Jan 30, 2023 |
| 18066149 | GENE THERAPY FOR AMYOTROPHIC LATERAL SCLEROSIS AND OTHER SPINAL CORD DISORDERS | KELLY, ROBERT M | 1638 | Non-Final OA | Dec 14, 2022 |
| 18051468 | TREATMENT OF OSTEOGENESIS IMPERFECTA | DUFFY, PATRICIA ANN | 1645 | Non-Final OA | Oct 31, 2022 |
| 18045995 | FGFR3 ANTIBODIES AND METHODS OF USE | ALLEN, MARIANNE P | 1647 | Non-Final OA | Oct 12, 2022 |
| 17878884 | METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA | WHITEMAN, BRIAN A | 1636 | Final Rejection | Aug 01, 2022 |
| 17843812 | ANTI-TGF-BETA ANTIBODY FORMULATIONS AND THEIR USE | BERHANE, SELAM | 1675 | Non-Final OA | Jun 17, 2022 |
| 17824552 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | SZNAIDMAN, MARCOS L | 1628 | Non-Final OA | May 25, 2022 |
| 17775446 | BIPARATOPIC CD73 ANTIBODIES | AEDER, SEAN E | 1642 | Final Rejection | May 09, 2022 |
| 17403592 | GLYCOENGINEERED ANTIBODY DRUG CONJUGATES | LEE, HOI YAN NMN | 1693 | Final Rejection | Aug 16, 2021 |
| 17428505 | METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASES | PIHONAK, SARAH | 1627 | Final Rejection | Aug 04, 2021 |
| 17375785 | METHODS AND COMPOSITIONS FOR TREATING A SERPINC1-ASSOCIATED DISORDER | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Jul 14, 2021 |
| 17162356 | MODIFIED ADENO-ASSOCIATED VIRAL CAPSID PROTEINS FOR OCULAR GENE THERAPY AND METHODS OF USE THEREOF | PENNINGTON, KATIE LEIGH | 1634 | Non-Final OA | Jan 29, 2021 |
| 17104593 | PHARMACEUTICAL COMPOSITIONS FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY | FERNANDEZ, SUSAN EMILY | 1651 | Non-Final OA | Nov 25, 2020 |
| 16807102 | METHODS FOR TREATING PROTEINOPATHIES | RODRIGUEZ-GARCIA, VALERIE | 1621 | Non-Final OA | Mar 02, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial